|
1
|
Grill S, Rusterholz C, Zanetti-Dällenbach
R, et al: Potential markers of preeclampsia - a review. Reprod Biol
Endocrinol. 7:702009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sibai B, Dekker G and Kupferminc M:
Pre-eclampsia. Lancet. 365:785–799. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dekker GA and Sibai BM: Etiology and
pathogenesis of preeclampsia: current concepts. Am J Obstet
Gynecol. 179:1359–1375. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hacker NF, Gambone JC and Hobel CJ: Hacker
and Moore’s Essentials of Obstetrics and Gynecology. 5th edition.
Elsevier and Saunders; Philadelphia, PA, USA: 2010
|
|
5
|
Chaiworapongsa T, Romero R, Espinoza J, et
al: Evidence supporting a role for blockade of the vascular
endothelial growth factor system in the pathophysiology of
preeclampsia. Young Investigator Award. Am J Obstet Gynecol.
190:1541–1550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maynard SE, Min JY, Merchan J, et al:
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may
contribute to endothelial dysfunction, hypertension, and
proteinuria in preeclampsia. J Clin Invest. 111:649–658. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu C, Zhang N, Yu H, Chen Y, Liang Y,
Deng H and Zhang Z: Proteomic analysis of human serum for Finding
pathogenic factors and potential biomarkers in preeclampsia.
Placenta. 32:168–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fleming CE, Nunes AF and Sousa MM:
Transthyretin: more than meets the eye. Prog Neurobiol. 89:266–276.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Su PH, Wang SL, Chen JY, Hu JM, Chang HP
and Chen SJ: Transthyretin levels are not related to Apgar score in
low birth weight and very low birth weight infants. Early Hum Dev.
84:533–538. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McKinnon B, Li H, Richard K and Mortimer
R: Synthesis of thyroid hormone binding proteins transthyretin and
albumin by human trophoblast. J Clin Endocrinol Metab.
90:6714–6720. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Landers KA, McKinnon BD, Li H, Subramaniam
VN, Mortimer RH and Richard K: Carrier-mediated thyroid hormone
transport into placenta by placental transthyretin. J Clin
Endocrinol Metab. 94:2610–2616. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wiseman RL, Powers ET and Kelly JW:
Partitioning conformational intermediates between competing
refolding and aggregation pathways: insights into transthyretin
amyloid disease. Biochemistry. 44:16612–16623. 2005. View Article : Google Scholar
|
|
13
|
Saraiva MJ: Transthyretin mutations in
hyperthyroxinemia and amyloid diseases. Hum Mutat. 17:493–503.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lv S, Gao J, Zhu F, et al: Transthyretin,
identified by proteomics, is overabundant in pancreatic juice from
pancreatic carcinoma and originates from pancreatic islets. Diagn
Cytopathol. 39:875–881. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Conde-Agudelo A, Villar J and Lindheimer
M: World Health Organization systematic review of screening tests
for preeclampsia. Obstet Gynecol. 104:1367–1391. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ahmed OM, El-Gareib AW, El-Bakry AM, Abd
El-Tawab SM and Ahmed RG: Thyroid hormones states and brain
development interactions. Int J Dev Neurosci. 26:147–209. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Haddow JE, Palomaki GE, Allan WC, et al:
Maternal thyroid deficiency during pregnancy and subsequent
neuropsychological development of the child. N Engl J Med.
341:549–555. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
LaFranchi S: Thyroid function in the
preterm infant. Thyroid. 9:71–78. 1999. View Article : Google Scholar
|
|
19
|
Pecks U, Seidenspinner F, Röwer C, Reimer
T, Rath W and Glocker MO: Multifactorial analysis of affinity-mass
spectrometry data from serum protein samples: a strategy to
distinguish patients with preeclampsia from matching control
individuals. J Am Soc Mass Spectrom. 21:1699–1711. 2010. View Article : Google Scholar
|
|
20
|
Espinoza J, Romero R, Nien JK, et al:
Identification of patients at risk for early onset and/or severe
preeclampsia with the use of uterine artery Doppler velocimetry and
placental growth factor. Am J Obstet Gynecol.
196:3262007.PubMed/NCBI
|
|
21
|
Llurba E, Carreras E, Gratacós E, et al:
Maternal history and uterine artery Doppler in the assessment of
risk for development of early- and late-onset preeclampsia and
intrauterine growth restriction. Obstet Gynecol Int.
2009:2756132009.PubMed/NCBI
|
|
22
|
Than NG, Romero R, Hillermann R, Cozzi V,
Nie G and Huppertz B: Prediction of preeclampsia - a workshop
report. Placenta. 29(Suppl A): S83–S85. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Reixach N, Deechongkit S, Jiang X, Kelly
JW and Buxbaum JN: Tissue damage in the amyloidoses: Transthyretin
monomers and nonnative oligomers are the major cytotoxic species in
tissue culture. Proc Natl Acad Sci USA. 101:2817–2822. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schweigert FJ, Wirth K and Raila J:
Characterization of the microheterogeneity of transthyretin in
plasma and urine using SELDI-TOF-MS immunoassay. Proteome Sci.
2:52004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hughes SE and McKenna WJ: New insights
into the pathology of inherited cardiomyopathy. Heart. 91:257–264.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Connors LH, Prokaeva T, Lim A, et al:
Cardiac amyloidosis in African Americans: comparison of clinical
and laboratory features of transthyretin V122I amyloidosis and
immunoglobulin light chain amyloidosis. Am Heart J. 158:607–614.
2009. View Article : Google Scholar
|
|
27
|
Lavatelli F, Perlman DH, Spencer B, et al:
Amyloidogenic and associated proteins in systemic amyloidosis
proteome of adipose tissue. Mol Cell Proteomics. 7:1570–1583. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hou X, Richardson SJ, Aguilar MI and Small
DH: Binding of amyloidogenic transthyretin to the plasma membrane
alters membrane fluidity and induces neurotoxicity. Biochemistry.
44:11618–11627. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Y and Zhang Z: Does transthyretin
function as one of contributors for preeclampsia? Med Hypotheses.
76:8–10. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Levine RJ, Vatten LJ, Horowitz GL, et al:
Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of
reduced thyroid function: nested case-control and population based
study. BMJ. 339:b43362009. View Article : Google Scholar : PubMed/NCBI
|
